After a meticulous proteomics and bioinformatics screening, the anti-CD63-AuNP probe was replaced with EphA2 (anti-EphA2-AuNP) as a pancreatic-cancer-specific EV marker. This evidence concerns the gene EPHA2 and pancreatic neoplasm.